Pulmozyme Side Effects
>>>Help Community - Post Your Pulmozyme Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Pulmozyme Side Effects
Pulmozyme Safety Reports reported to FDA
Total Pulmozyme reports: 9.Pulmozyme FDA safety alerts: No.
Reported hospitalizations: 4.
Take Pulmozyme Side Effects Survey or Share Your Pulmozyme Story.
Reported Pulmozyme Side Effects: tracheostomy infection, bronchospasm, neoplasm malignant, staphylococcal infection, pathogen resistance, pulmonary haemorrhage, upper respiratory tract infection, tracheostomy malfunction, oxygen saturation decreased, cardiac arrest, bradycardia.
More About Pulmozyme.
If you have questions about Pulmozyme, you can post them to our Doctors or Ask Patient Community about Pulmozyme.
Pulmozyme Side Effects Report #5216883-1
Health Professional from UNITED STATES reported PULMOZYME problem on Jan 17, 2007. Female patient was diagnosed with cystic fibrosis and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: pathogen resistance, staphylococcal infection, tracheostomy infection. PULMOZYME dosage: unknown. During the same period patient was treated with PULMICORT, XOPENEX. Patient recovered.
Pulmozyme Side Effects Report #5242113-0
PULMOZYME problem was reported by a Pharmacist from UNITED STATES on Feb 03, 2007. Male patient, 23 years of age, was diagnosed with cystic fibrosis and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, neoplasm malignant. PULMOZYME dosage: unknown. Patient was hospitalized. Patient recovered.
Pulmozyme Side Effects Report #5290924-8
Consumer or non-health professional from UNITED STATES reported PULMOZYME problem on Apr 07, 2007. Male patient, 23 years of age, was diagnosed with cystic fibrosis and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: neoplasm malignant. PULMOZYME dosage: unknown. Patient was hospitalized. Patient recovered.
Pulmozyme Side Effects Report #5312719-9
PULMOZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Male patient was diagnosed with pneumonia and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: loss of consciousness. PULMOZYME dosage: 2.5 MG, SINGLE. Patient was hospitalized. Patient recovered.
Pulmozyme Side Effects Report #5062454-X
Consumer or non-health professional from UNITED STATES reported PULMOZYME problem on July 20, 2006. Male patient, 52 years of age, was diagnosed with cystic fibrosis and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: bronchospasm, pyrexia. PULMOZYME dosage: unknown. Patient was hospitalized. Patient recovered.
Pulmozyme Side Effects Report #5107562-X
PULMOZYME problem was reported by a Pharmacist from UNITED STATES on Sept 13, 2006. Male patient, weighting 9.04 lb, was diagnosed with respiratory failure and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: bradycardia, bronchospasm, cardiac arrest, oxygen saturation decreased. PULMOZYME dosage: 2.5 MG 2 TIMES DAILY INHAL. Patient recovered.
Pulmozyme Side Effects Report #5113271-3
Health Professional from UNITED STATES reported PULMOZYME problem on Sept 11, 2006. Female patient was diagnosed with cystic fibrosis and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: pathogen resistance, staphylococcal infection, tracheostomy malfunction, upper respiratory tract infection. PULMOZYME dosage: unknown. During the same period patient was treated with PULMICORT, XOPENEX. Patient recovered.
Pulmozyme Side Effects Report #5139317-4
PULMOZYME problem was reported by a Health Professional from UNITED STATES on Oct 11, 2006. Female patient was diagnosed with cystic fibrosis and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: tracheostomy, tracheostomy infection. PULMOZYME dosage: unknown. During the same period patient was treated with PULMICORT, XOPENEX. Patient recovered.
Pulmozyme Side Effects Report #5464603-8
Consumer or non-health professional from UNITED STATES reported PULMOZYME problem on Sept 13, 2007. Male patient, 14 years of age, was diagnosed with cystic fibrosis and was treated with PULMOZYME. After drug was administered, patient experienced the following problems/side effects: pulmonary haemorrhage. PULMOZYME dosage: 2.5 ML, QOD. Patient recovered.